RxDoctor Payments Data

Karim Fram

Clinical Neurophysiology · Lapeer, MINPI 1265478671

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 482 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,716 and has fallen 56.2% since, to $1,190 in 2022.

$6,487in general payments, 2019–2025

Across 482 payments — averaging $13.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$870
  • Novartis$661
  • UCB, Inc.$530
  • MDD US Operations, LLC$378
  • Teva Pharmaceuticals USA, Inc.$374
  • Amgen$331
  • plus $3K from 35 others

What the payments were for

  • Speaking & faculty fees$901%
  • Food & beverage$6,36798%
  • Education$290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few clinical neurophysiology providers in Michiganto place this figure against a meaningful peer group, so we don't.

Other clinical neurophysiology in Lapeer

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →